Australia markets closed

Xeris Biopharma Holdings, Inc. (XERS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7150+0.0150 (+0.88%)
As of 02:13PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6665
Avg. Estimate-0.12-0.1-0.38-0.22
Low estimate-0.14-0.12-0.47-0.35
High estimate-0.11-0.09-0.29-0.13
Year ago EPS-0.12-0.14-0.45-0.38
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate41.81M45.1M184.43M219.33M
Low estimate37.97M43.88M176.7M195.2M
High estimate44M47.6M194.2M230.4M
Year ago sales33.2M38.01M163.91M184.43M
Sales growth (year/est)25.90%18.70%12.50%18.90%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.17-0.13-0.12-0.1
Actual EPS-0.12-0.14-0.09-0.1
Difference0.05-0.010.030
Surprise %29.40%-7.70%25.00%0.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.12-0.1-0.38-0.22
7 days ago-0.12-0.1-0.38-0.22
30 days ago-0.12-0.1-0.37-0.22
60 days ago-0.09-0.07-0.27-0.05
90 days ago-0.09-0.07-0.29-0.06
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXERSIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.28.60%N/AN/AN/A
Current year15.60%N/AN/AN/A
Next year42.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A